Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer

BACKGROUND: PREDICT (http://www.predict.nhs.uk) is a prognostication and treatment benefit tool for early breast cancer (EBC). The aim of this study was to incorporate the prognostic effect of KI67 status in a new version (v3), and compare performance with the Predict model that includes HER2 status...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Wishart, Gordon C, Rakha, Emad, Green, Andrew, Ellis, Ian, Ali, Hamid Raza, Provenzano, Elena, Blows, Fiona M, Caldas, Carlos, Pharoah, Paul DP
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2014
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4265394/
https://ncbi.nlm.nih.gov/pubmed/25472026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-908
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi